Evidence map›Paper›PMID 29161287›Full record

ArticlePloS one2017

TGF-β contamination of purified recombinant GDF15.

Oddrun Elise Olsen, Anette Skjærvik, Berit Fladvad Størdal, Anders Sundan, Toril Holien

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. AAV-NRF2 protects retinal and choroidal vasculature in a GDF15-dependent manner in an oxidative damage model of AMD.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. GDF15: An emerging disease target and biomarker of metabolic diseases.Journal of endocrinological investigation · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Proximate and ultimate causes of pregnancy sickness.Evolution, medicine, and public health · 2025
    Review
  17. Article
  18. Article
  19. Macrophages as a Source and Target of GDF-15.International journal of molecular sciences · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oddrun Elise OlsenDepartment of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
Anette SkjærvikDepartment of Biotechnology, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
Berit Fladvad StørdalDepartment of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
Anders SundanDepartment of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
Toril HolienDepartment of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.ORCID http://orcid.org/0000-0002-2051-5824

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purified recombinant proteins for use in biomedical research are invaluable to investigate protein function. However, purity varies in protein batches made in mammalian expression systems, such as CHO-cells or HEK293-cells. This study points to caution while investigating effects of proteins related to the transforming growth factor (TGF)-β superfamily. TGF-β itself is a very potent cytokine and has effects on cells in the femtomolar range. Thus, even very small amounts of contaminating TGF-β in purified protein batches may influence the experimental results given that receptors for TGF-β are present. When we attempted to characterize possible receptors for the TGF-β superfamily ligand GDF15, striking similarities between GDF15-induced activities and known TGF-β activities were found. However, differences between batches of GDF15 were a concern and finally led us to the conclusion that the measured effects were caused by TGF-β and not by GDF15. Our results emphasize that purified recombinant proteins must be used with caution and warrant proper controls. Notably, some conclusions made about GDF15 in already published papers may not be supported by the results shown. Awareness about this issue in the scientific community may prevent spreading of false positive results.

Indexed as

AnimalsCell DifferentiationCell Line, TumorCHO CellsCricetulusGene ExpressionGrowth Differentiation Factor 15HumansPhosphorylationRecombinant ProteinsRNA, Small InterferingSignal TransductionSmad ProteinsTransforming Growth Factor betaGDF15 protein, humanGrowth Differentiation Factor 15Recombinant ProteinsRNA, Small InterferingSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID29161287
PMCPMC5697882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.